Shire has made a €428 million offer for Belgium-based Movetis in a bid to grow its business in Europe and …
NICE has provisionally recommended Belgium-based Movetis’s Resolor as an option for the treatment of chronic constipation in women where laxatives …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

